- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Brett Villagrand, Genentech
S
Brett Villagrand
Associate Director, Strategy, BioOncology, Genentech
BORN: Australia; has lived in four countries
CAN'T LIVE WITHOUT: Rugby
On brand success:
Herceptin revolutionized the way to treat HER2-positive breast cancer. I've been fortunate enough to work on that brand for the last three years—and to be here at Genentech at the right time. We've been fairly successful, with sales at around $1.3 billion. It's been a roller coaster ride to get there because the brand's more than doubled its growth over the last four or five years. Now we're facing competition for the first time. But despite the entry of a new competitor, we've been able to keep them to less than 5 percent of the market. Far from resting, we've instead put a number of things in place that will help us maintain our leadership role in that area.
Brett Villagrand
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start
October 30th 2024By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.
